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Introduction: Antifungal resistant is one of the causes of high mortality rates during 
invasive candidiasis. Since development of new antifungal agents is limited, researchers have 
focused on natural products including essential oils (EOs) with antifungal properties. In 
immunocompromised patients fungicidal activity is of benefit. This study was designed to 
evaluate chemical composition and fungicidal/fungistatic activities of five Iranian EOs and 
against fluconazole resistant Candida species.
Methods: To determine chemical composition of EOs gas chromatography-mass spectroscopy 
(GC/MS) was employed. Fluconazole resistant Candida species were chosen and minimum 
inhibitory concentration (MIC) values of studied EOs were determined by broth microdilution 
method. Minimum fungicidal concentration (MFC) was determined as the lowest concentration 
with no fungal growth on solid media. Fungicidal activity was calculated by MFC/MIC ratio.
Results: The results showed that C. albicans and C. tropialis isolates were susceptible to 
itraconazole (ITC) and voriconazole (VRC) while one species of C. glabrata and C. krusei each 
was resistant to itraconzaole; and itraconazole resistant C. glabrata isolate was resistance to 
voriconzaole as well. Among tested EOs, the ones from Cinnamomum cayennense, Origanum 
majorana var. majoranoides and Andropogon citratus had the highest anti-Candida activity. 
Artemisia aromatica A. Nelson had the highest MIC value against Candida isolates. All EOs in 
this study had fungicidal activity. 
Conclusion: In general, the tested natural compounds are suitable to be used as anti-Candida. 
However more studies are needed on each chemical compound to evaluate its antifungal activity 
alone or in combination with other agents.
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Introduction
Incidence of invasive fungal infections (IFIs) has been 
increased in recent years (1). Candida species are the most 
frequent fungal pathogens isolated from IFIs. Although 
infections with Candida albicans have been the most 
prevalent, infections due to non-albicans Candida have 
been increased significantly in the last decades (2,3). The 
increase in prevalence of these species might be as a result 
of higher resistance to conventional antifungals (4). 
Development of new antifungals is challenging; because 
there are only few targets for antifungal actions and 
toxicity level of many antifungals is relatively high 
(5). In recent years, some researchers have focused on 
natural compounds including essential oils (EOs) and 
herbal extracts derived from medicinal plants and other 
biomaterials with antifungal activities (6). EOs are 
aromatic compounds derived from plant materials (7). 
EOs have shown to possess antimicrobial, insecticidal 
and antioxidant properties (8). It is believed that these 
properties are related to the functions of their components 
in plants (9). Iran is a country rich in medicinal plants and 
EOs from these plants could be potent antifungals (10). 
Conventional antifungals are divided into 2 groups of 
fungicidal and fungistatic compounds (11). Fungicidal 
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activity of antifungals is a benefit in most IFIs, especially in 
early stages of the disease, including systemic candidiasis, 
cryptococcal meningitis in HIV patients and aspergillosis 
in immunocompromised individuals (12,13). This study 
was designed to evaluate the fungicidal and/or fungistatic 
activities of 5 Iranian EOs against fluconazole (FLC) 
resistant Candida species and to study the effect of EOs’ 
chemical compositions on their antifungal properties. 
Materials and Methods
Isolation of Candida species
Candida species were isolated from patients having 
candidiasis, referred to Mycology Research Center, 
Faculty of Veterinary Medicine, University of Tehran, 
Tehran, Iran, during 2016-2018. A total of 50 isolates from 
different organs were cultured on Sabouraud Dextrose 
agar (Merck, Germany) at 30°C for 7 days. Candida 
isolates were identified by germ tube test and RAPID yeast 
plus system (Remel Inc., Lenexa, KS, USA). Isolates were 
kept at 4°C before use (14).
Preparation of essential oils
In the present study, leaves of Artemisia aromatica A. 
Nelson, Andropogon citratus and Origanum majorana 
var. majoranoides, bark of Cinnamomum cayennense and 
flower buds of Syzygium aromaticum were purchased 
from Pakan Bazr Company, Isfahan, Iran. The plants 
were authenticated taxonomically at Pharmacognosy 
Department, Faculty of Pharmacy, University of Tehran, 
Iran.
EOs were extracted by hydro-distillation of plant parts in 
a Clevenger-type apparatus at 100°C for 5 hours. The EOs 
were collected and dried over anhydrous sodium sulfate. 
The chemical composition of each EO was analyzed using 
a 6890 N Agilent Gas chromatograph coupled to a 5975 
C Agilent Mass-selective detector (Agilent Technologies, 
Avondale, PA, USA) (15). EOs were stored in a dark glass 
bottle at 4°C until used.
Preparation of antifungal agents
FLC, itraconazole (ITC) and voriconazole (VRC) 
standards were prepared from Sigma Company (Sigma, 
St. Louis, MO, USA). Antifungal stocks were prepared by 
dissolving 64 mg antifungal in 50 mL DMSO. Stocks were 
kept at -20°C before use.
Determination of minimum inhibitory concentration 
Broth microdilution method was used to study antifungal 
susceptibility of Candida isolates to mentioned antifungal 
agents and studied EOs according to Clinical and 
Laboratory Standards Institute (CLSI) M27-A3 document. 
In brief, 2 fold serial dilutions of EOs (15.6, 31.2, 62.5, 
125, 175,250, 350, 500, 700, 1000 and 2000 µg/mL) and 
3 azole agents (0.031-64 µg/mL) were prepared in 96-well 
plates using RPMI-1640 media (Sigma, St. Louis, MO, 
USA) buffered with MOPS (Sigma, St. Louis, MO, USA). 
Candida inoculums were adjusted to density of 1 × 103- 
5 × 103 CFU/mL with the help of a hemocytometer and 0.1 
mL of each inoculum was added to microplate wells which 
were incubated at 30°C for 24-48 hours. Non-inoculated 
medium (200 mL) was considered as negative control 
(blank), and the well with no EO/azole was spotted as 
positive control. The growth in each well was compared 
with the growth in the control well. Minimum inhibitory 
concentrations (MICs) were visually determined and 
defined as the lowest concentration of the EO/azole which 
inhibited growth in comparison with positive control. All 
tests were done in replicates of three (16).
Determination of minimum fungicidal concentration 
Wells with no visible growth after 48 hours of incubation 
were cultured on Sabouraud Dextrose Agar by surface 
plate count method. Plates were incubated at 30°C for 
10 days. Minimum fungicidal concentration (MFC) was 
determined as the lowest concentration with no growth on 
solid media. All experiments were done with 3 replicates 
(17).
MFC/MIC ratio
EOs were considered fungicidal if the ratio of MFC to 
MIC was less or equal to 4 and if the ratio was higher than 
four the EO was deemed fungistatic (18). 
Statistical analysis
Data were analyzed using SPSS version 21. Analysis of 
variance (ANOVA) and Dunnett post hoc test were done 
to compare different data. A P value of less than 0.05 was 
considered significant.
Results
Isolation of Candida species
Specimens were taken from upper respiratory tract, 
urine and blood. Candida isolates were initially tested 
for susceptibility to FLC by broth microdilution method. 
Isolates with MIC range of 64 or greater were considered 
resistant to FLC. A total of 12 Candida species that were 
resistant to FLC were selected for further studies. These 
isolates included C. albicans (6 isolates), Candida glabrata 
(3 isolates), Candida krusei (2 isolates) and Candida 
tropicalis (1 isolate). 
Analysis of essential oils by Gas chromatography/ Mass 
spectrometry 
EOs were analyzed on a 6890 N Agilent Gas chromatograph 
coupled to a 5975 C Agilent mass-selective detector 
(Agilent Technologies, Avondale, PA, USA) with a 7683 
Agilent auto sampler. In brief, 1 µL of each sample was 
injected in the split less mode at 250°C/into a 30 m × 0.25 
mm × 0.5 µm DB-5 MS capillary column and operated by 
MSD Chemstation software (Agilent Technologies). 
The temperature program used for the chromatographic 
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separation was 50°C/2 min; 25◦C/1 min; 100°C/2 
min; 5°C/1 min and 290◦C/5 min. The carrier gas was 
helium (99.999%) with a constant flux of 1.0 mL/min. 
Mass spectrometry was operated in an electron impact 
ionization mode with the energy of 70 eV. Several 
unknown peaks were observed after injection. Peaks were 
identified using computer library. The main components 
of the EOs are summarized in Table 1. 
Major compounds of A. aromatica A. Nelson were 
Anethole (22.02%), d-limonene (14.93%) and alpha pinene 
(16.44%). Isothymol (59.42%), thymol (15.23%) and trans-
caryophyllene (10.18%) were the major constituents of 
A. citratus; while carvacrol (57.86%), thymol (13.54%) 
and trans-caryophyllene (11.52%) were the main 
compounds found in O. majorana var. majoranoides. C. 
cayennense was mainly composed of cinnamaldehyde 
(62.06%), cinnamaldehyde dimethyl acetate (8.14%) and 
eugenol (7.49%). We found eugenol (96.81%) as the main 
component of S. aromaticum followed by lower percentages 
of carvacrol (1.74%) and Trans-Caryophyllene (0.39%).
Determination of MIC and MFC 
Antifungal susceptibility test of EOs in comparison with 
ITC and VRC against FLC resistant Candida species 
was done using broth micro dilution method (Table 2). 
All C. albicans and C. tropicalis isolates were susceptible 
to both ITC and VRC. Whereas, isolates of C. krusei 
and C. glabrata were resistant to ITC. ITC resistant C. 
glabrata was resistant to VRC as well. Among EOs, MICs 
of A. aromatica A. Nelson, A. citratus, O. majorana var. 
majoranoides, C. cayennense and S. aromaticum ranged 
between 1000 to 2000 µg/mL (mean value: 1454.5 ± 
509.6 µg/mL), 125 to 175 µg/mL (mean value: 156.8 ± 
24.6 µg/mL), 173 to 350 µg/mL (mean value: 208 ± 55.8 
µg/mL), 125 to 175 µg/mL (mean value: 147.7 ± 25.5 
µg/mL) and 700 to 1000 µg/mL (mean value: 740.9 ± 
105.4 µg/mL), respectively. O. majorana var. majorana 
had significantly higher MICs for C. glabrata than other 
examined Candida species (P<0.05). The MIC ranges of 
other EOs against Candida species were not statistically 
significant (P > 0.05). C. cayennense could significantly 
inhibit growth of C. albicans in lower concentrations than 
O. majorana var. majoranoides, S. aromaticum and A. 
aromatica A. Nelson (P < 0.05). Whilst it was only more 
effective than O. majorana var. majoranoides against C. 
glabrata isolates (P < 0.05). The most effective EOs on C. 
krusei isolates were A. citratus and C. cayennense (P < 0.05); 
and O. majorana var. majoranoides was significantly more 
effective against C. tropicalis than A. aromatica A. Nelson 
and C. cayennense (P < 0.05).
Determination of fungicidal activity
The ration of MIFC/MIC of studied EOs against Candida 
isolates is shown in Figure 1. Since the MIC/MFC ratios 
of all EOs in this study were less than 4, they could be 
considered fungicidal. C. cayennense MIC/MFC ratio was 
similar for all Candida species. While A. aromatica A. 
Nelson had the nearest ratio against C. krusei and other 
essences had the lowest ratio for C. tropicalis. 
Discussion
Candida species cause a variety of fungal infections from 
superficial candidiasis of oral and vaginal mucosa to 
disseminated and deep tissue infections. These infections 
are most often caused by C. albicans followed by C. glabrata, 
C. parapsilosis/C. tropicalis and C. krusei according to 
epidemiological studies in different geographical regions 
(19). FLC, an azole antifungal, is the most common 
antifungal used for treatment of candidiasis. It inhibits 
lanesterol 14 α demethylase enzyme encoded by ERG11 
gene. However, some non albicans Candida species have 
intrinsic resistant to azoles. In addition, Candida spp. are 
able to develop resistant to azoles (20,21). Azole resistance 
is seen especially in patients receiving azole prophylaxis 
(22). 
In this study we examined the fungicidal activities of 
5 Iranian EOs on FLC resistant to Candida species. 
Candida yeasts were isolated from candidiasis cases. 
Resistant to other conventional systemic azoles in Iran 
was investigated as well. In our study only one isolate of C. 
glabrata was resistant to VRC and one isolate of C. glabrata 
as well as C. krusei were dose dependently susceptible 
to ITC. According to recent studies, resistance to azole 
antifungals has increased in recent years. Widespread 
use of triazoles has resulted in emergence of resistant to 
non albicans Candida species including C. glabrata and 
C. krusei (23,24). These species have intrinsic resistant to 
FLC and it is said that this inherited resistance could be 
seen in VRC as well (23). In our study only one isolate of 
C. glabrata was resistant to VRC. Studies have shown that 
mutations in ERG11 gene could induce azole resistance in 
C. albicans (24). Stephanie et al demonstrated that there is 
a combination effect between FLC and VRC susceptibility 
in C. albicans strains, while ITC susceptibility is not 
affected (24). We did not observe any correlation between 
FLC and VRC susceptibility among our C. albicans isolates. 
It might be due to different mutation regions in our 
isolates. Biological activity of EOs is highly related to their 
chemical compounds (25). In our study, C. cayennense 
was the most effective one against Candida isolates. 
GS/MS analysis revealed cinnamaldehyde, 
cinnamaldehyde dimethyl acetal and eugenol as its main 
ingredients. Other studies have demonstrated that the 
amount of cinnamaldehyde affect antifungal activity of 
Cinnamomum spp. The higher cinnamaldehyde content 
the higher antifungal activity would be (26). O. majorana 
var. majoranoides and A. citratus had the best anti Candida 
activity following C. cayennense. GC/MS analysis revealed 
that isothymol and thymol compromised approximately 
50% of A. citratus. These compounds are known for 
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their antifungal activities (27). Another compound with 
high value in A. citratus was Trans-Caryophyllene. It is 
sesquiterpene found in many EOs especially cloves (28). 
Trans-Caryophyllene is known for its anti-inflammatory 
and pain killer effects (29). S. aromaticum activity against 
FLC resistant Candida species was also suitable (MIC = 700 
µ/mL). Only one isolate of C. glabrata and C. krusei had 
the MIC of 1000 µg/mL. Other studies have demonstrated 
a suitable antifungal activity for eugenol in vivo and in 
vitro (30). A. aromatica A. Nelson was found to have the 
lowest antifungal activity against the studied Candida 
species in our study. Since the numbers of isolates were 
not similar in our study, we could not predict if the tested 
EOs act differently on various Candida species, although 
according to our results there was no difference between 
FLC resistant Candida species. 
All EOs in our study had fungicidal properties. It has 
been documented that fungicidal activity of antifungals 
is related to more therapeutic success and less recurrent 
and persistent infection especially in invasive candidiasis 
and candidemia (12,13). It has been shown that fungicidal 
compounds inhibit morphogenic transformation of 
Candid spp while fungistatics do not affect morphogenesis 
(18). 
Conclusion
In conclusion, EOs in this study have potential antifungal 
effects against Candida species and there is no known 
resistant mechanism in Candida species against 
studied EOs. These EOs are probably suitable to be 
used as supplementary agents along with conventional 
antifungals. However more studies are needed to evaluate 
their safety on host cells and to examine the effects of their 
chemical compounds alone and/or in combination with 
Table 2. Antifungal susceptibility test of selected essential oils in comparison with 3 conventional azole antifungals against Candida isolates
Candida 
isolates
Itranconazole Voriconazole Artemisia aromatica A. Nelson
Andropogon 
citratus
Origanum majorana 
var. majoranoides
Cinnamomum 
cayennense
Syzygium 
aromaticum
MIC MFC MIC MFC MIC MFC MIC MFC MIC MFC MIC MFC MIC MFC
C. albicans1 0.125 <0.5 0.125 <0.5 2000 2000 175 350 175 350 125 175 700 1000
C. albicans2 0.062 <0.5 0.062 <0.5 1000 2000 175 350 175 350 125 175 700 1000
C. albicans3 0.062 <0.5 0.062 <0.5 1000 2000 175 350 175 350 125 175 700 1000
C. albicans4 0.062 <0.5 0.062 <0.5 2000 2000 175 350 250 350 125 175 700 1000
C. albicans5 0.062 <0.5 0.062 <0.5 1000 2000 125 350 175 350 125 175 700 1000
C. albicans6 0.062 <0.5 0.062 <0.5 1000 2000 125 175 175 350 125 175 700 1000
C. glabrata1 4 <64 8 <64 1000 2000 175 250 175 250 175 250 700 1000
C. glabrata2 0.125 <0.5 0.25 <1 1000 2000 175 250 175 250 175 250 700 700
C. glabrata3 0.125 <0.5 0.125 <0.5 2000 2000 125 175 175 350 175 250 1000 1000
C. krusei1 0.062 <0.5 0.062 <0.5 2000 2000 125 175 350 500 125 175 1000 1000
C. krusei2 4 <64 0.5 <2 1000 2000 125 175 350 500 125 175 700 1000
C. tropicalis 0.5 <2 0.125 <0.5 1000 2000 175 175 175 175 175 250 700 700
Data are shown as mean (µg/mL).
Figure 1. (A) Comparison the MIC/MFC ratio of different essential oils against C. albicans, C. glbrata, C. krusei and C. tropicalis. Data are shown 
as mean±SE. (B) a diagram on relative MIC/MFC ration of studied essential oils.
(A) (B)
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other agents.
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